CLDI

Calidi Biotherapeutics develops cancer therapies using specially engineered viruses that target and destroy tumor cells. These treatments are designed for cancer patients who need alternatives to traditional chemotherapy and radiation. The company makes money by advancing these therapies through clinical trials and seeking regulatory approval, with potential future revenue from drug sales if treatments prove successful and reach the market.